Sarah Fitt: Pharmac CEO on the $1.7 billion funding-boost in the upcoming Budget

Published: April 29, 2024, 7:51 p.m.

Pharmac's record funding-boost will address the fiscal cliff it faces.\xa0

An additional $1.7 billion spread over four-years has been ear-marked for the drug-buying agency in the upcoming Budget.\xa0

Chief Executive Sarah Fitt told Mike Hosking that the extra cash covers time-limited funding for some treatments, which ends this year.\xa0

She says the fiscal hole was always known, as the funds outlined in Budget 2022 only went through to Budget 2024.\xa0

LISTEN ABOVE\xa0\xa0\xa0

See omnystudio.com/listener for privacy information.